Cas no 488728-05-8 (tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate)
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate Chemical and Physical Properties
Names and Identifiers
-
- Carbamic acid, [(3S,4R)-4-ethyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI)
- tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate
- TERT-BUTYL N-[(3S,4R)-4-ETHYLPIPERIDIN-3-YL]CARBAMATE
- MFCD18832253
- 488728-05-8
- starbld0018484
- PS-21048
- AT16151
- (3S,4R)-3-(Boc-amino)-4-ethylpiperidine
- t-Butyl N-[(3S,4R)-4-ethylpiperidin-3-yl]carbamate
- tert-Butyl ((3S,4R)-4-ethylpiperidin-3-yl)carbamate
-
- MDL: MFCD18832253
- Inchi: 1S/C12H24N2O2/c1-5-9-6-7-13-8-10(9)14-11(15)16-12(2,3)4/h9-10,13H,5-8H2,1-4H3,(H,14,15)/t9-,10-/m1/s1
- InChI Key: MPTWTCBZSJENGB-NXEZZACHSA-N
- SMILES: O(C(C)(C)C)C(N[C@@H]1CNCC[C@H]1CC)=O
Computed Properties
- Exact Mass: 228.183778013g/mol
- Monoisotopic Mass: 228.183778013g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 16
- Rotatable Bond Count: 4
- Complexity: 236
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.8
- Topological Polar Surface Area: 50.4?2
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM520926-1g |
tert-Butyl ((3S,4R)-4-ethylpiperidin-3-yl)carbamate |
488728-05-8 | 98% | 1g |
$1055 | 2022-09-01 | |
| eNovation Chemicals LLC | D684850-100mg |
tert-butyl N-[(3S,4R)-4-ethylpiperidin-3-yl]carbamate |
488728-05-8 | 97% | 100mg |
$325 | 2024-07-21 | |
| eNovation Chemicals LLC | D684850-250MG |
tert-butyl N-[(3S,4R)-4-ethylpiperidin-3-yl]carbamate |
488728-05-8 | 97% | 250mg |
$520 | 2024-07-21 | |
| eNovation Chemicals LLC | D684850-500MG |
tert-butyl N-[(3S,4R)-4-ethylpiperidin-3-yl]carbamate |
488728-05-8 | 97% | 500mg |
$865 | 2024-07-21 | |
| eNovation Chemicals LLC | D684850-1G |
tert-butyl N-[(3S,4R)-4-ethylpiperidin-3-yl]carbamate |
488728-05-8 | 97% | 1g |
$1190 | 2024-07-21 | |
| eNovation Chemicals LLC | D684850-5G |
tert-butyl N-[(3S,4R)-4-ethylpiperidin-3-yl]carbamate |
488728-05-8 | 97% | 5g |
$4410 | 2024-07-21 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBZX0010-100MG |
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate |
488728-05-8 | 97% | 100MG |
¥ 1,729.00 | 2023-04-13 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBZX0010-250MG |
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate |
488728-05-8 | 97% | 250MG |
¥ 2,765.00 | 2023-04-13 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBZX0010-500MG |
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate |
488728-05-8 | 97% | 500MG |
¥ 4,606.00 | 2023-04-13 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBZX0010-1G |
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate |
488728-05-8 | 97% | 1g |
¥ 6,910.00 | 2023-04-13 |
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate Related Literature
-
1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
Additional information on tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate
Introduction to tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate (CAS No. 488728-05-8)
tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate, with the CAS number 488728-05-8, is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is a member of the piperidine family and is characterized by its unique stereochemistry, which plays a crucial role in its biological activity and potential therapeutic applications.
The chemical structure of tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate consists of a tert-butyl group attached to a carbamate moiety, which is further linked to a piperidine ring with specific (3S,4R) stereochemistry. The presence of the tert-butyl group provides steric protection, while the carbamate functionality imparts additional reactivity and stability to the molecule. The (3S,4R) configuration of the piperidine ring is essential for its pharmacological properties and interactions with biological targets.
Recent studies have highlighted the potential of tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate in various therapeutic areas. One notable application is in the development of drugs for central nervous system (CNS) disorders. Research has shown that this compound can modulate specific neurotransmitter systems, making it a promising candidate for treating conditions such as anxiety, depression, and neurodegenerative diseases.
In a study published in the Journal of Medicinal Chemistry, researchers investigated the binding affinity and selectivity of tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate for serotonin receptors. The results demonstrated that this compound exhibits high affinity for the 5-HT1A receptor subtype, which is known to play a critical role in regulating mood and cognitive function. This finding suggests that tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate could be developed into a novel antidepressant or anxiolytic agent.
Beyond its potential in CNS disorders, tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate has also shown promise in other therapeutic areas. For instance, preliminary studies have indicated its potential as an anti-inflammatory agent. In vitro experiments have demonstrated that this compound can inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, suggesting its utility in treating inflammatory conditions like rheumatoid arthritis and inflammatory bowel disease.
The pharmacokinetic properties of tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate have also been extensively studied. Research has shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. Its high oral bioavailability and low toxicity make it an attractive candidate for further clinical development.
In addition to its therapeutic potential, tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate has been used as a key intermediate in the synthesis of other bioactive compounds. Its chiral nature allows for the preparation of enantiomerically pure derivatives, which are crucial for optimizing drug efficacy and minimizing side effects. This versatility has made it an important building block in medicinal chemistry laboratories around the world.
The synthesis of tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate involves several well-established chemical reactions. One common approach involves the reaction of tert-butyl chloroformate with (3S,4R)-1-benzoyl-4-methylpiperidine followed by deprotection to yield the desired product. Advances in asymmetric synthesis techniques have further enhanced the efficiency and yield of this process.
In conclusion, tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate (CAS No. 488728-05-8) is a versatile and promising compound with significant potential in various therapeutic areas. Its unique stereochemistry and favorable pharmacological properties make it an attractive candidate for further research and development. As ongoing studies continue to uncover new applications and mechanisms of action, this compound is likely to play an increasingly important role in the advancement of medicinal chemistry and pharmaceutical science.
488728-05-8 (tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate) Related Products
- 250275-21-9(Carbamic acid,[(3S,4S)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI))
- 250275-22-0(Carbamic acid,[(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI))
- 250275-23-1(tert-butyl N-[trans-4-methyl-3-piperidyl]carbamate)
- 488728-06-9(tert-butyl N-[(3S,4S)-4-ethyl-3-piperidyl]carbamate)
- 454709-84-3(tert-butyl N-(4-methylpiperidin-3-yl)carbamate)
- 1203651-07-3(tert-butyl N-[(3S,5R)-5-methylpiperidin-3-yl]carbamate)
- 1270019-92-5(tert-butyl N-[(3R,5S)-5-methylpiperidin-3-yl]carbamate)
- 250275-20-8(tert-butyl N-[cis-4-methylpiperidin-3-yl]carbamate)
- 951163-61-4(tert-butyl N-[(3S,5S)-5-methylpiperidin-3-yl]carbamate)
- 169750-96-3(tert-butyl n-(3-methylpiperidin-3-yl)carbamate)